trial

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

NCTId NCT01053429
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 3,391 (actual)
Sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Primary completion 2010-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
3,391 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2005-06
Primary completion
2010-02
Eligibility
ALL

Interventions & indications

Drugs
Ziprasidone

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Lead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
3,391
Phase
NA
Primary Completion Date
2010-02
Status
COMPLETED
relationships
The graph out of here
drug
Ziprasidone
drug
lead_sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
company
indication
Schizophrenia
indication
Bipolar Disorder
indication
Bipolar Disorder
indication